Arrakis Therapeutics is a biopharmaceutical company which offers a drug discovery platform intended to target RNA. The Company develops an internal product pipeline of RNA-targeted small molecules focused on neurology, oncology, and rare genetic disorders. It offers scientific platforms, such as TRYST, MARS, PEARL-Seq, to identify tractable RNA targets, design drug molecules, and select candidates for clinical development.